| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $506.9M | +48.7% |
| R&D Expense | $64.9M | +3.6% |
| SG&A Expense | $132.0M | +26.6% |
| Operating Income | $117.5M | +1172.6% |
| Pre-tax Income | $113.7M | +414.6% |
| Income Tax | -$20.6M | -1046.5% |
| Net Income | $133.9M | +677.6% |
| EPS (Basic) | $0.54 | — |
| EPS (Diluted) | $0.44 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.20B | +317.1% |
| Accounts Receivable | $52.0M | +147.7% |
| Current Assets | $1.86B | +117.8% |
| Total Assets | $2.32B | +99.9% |
| Current Liabilities | $846.0M | +35.2% |
| Long-term Debt | $557.2M | +17.8% |
| Total Liabilities | $1.08B | +35.7% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $62.6M | +149.3% |
| Investing Cash Flow | -$61.3M | -63.6% |
| Financing Cash Flow | $918.0M | +173.1% |
| $1.23B |
| +246.1% |